Propranolol Dosing for Anxiety
For acute situational anxiety (performance anxiety/stage fright), use propranolol 20-40 mg as a single dose 1-2 hours before the anxiety-provoking event; for chronic generalized anxiety disorder, propranolol is NOT recommended as first-line therapy based on current evidence.
Acute Situational Anxiety (Performance Anxiety)
The optimal dose is 20-40 mg taken orally 1-2 hours before the anticipated stressful event 1, 2. This dosing strategy specifically targets the peripheral somatic symptoms of anxiety (tremor, palpitations, sweating) that occur during public speaking, musical performances, or other discrete performance situations.
Key Evidence for Acute Use:
- 20 mg provides significant anxiolysis with minimal side effects and is the preferred starting dose 1
- 40 mg is equally effective but carries higher risk of bradycardia (25%) and hypotension (10%) 1
- Clinical effect begins within 1-2 hours of administration 3
- Works primarily through peripheral beta-receptor blockade, reducing tremor and palpitations 2
Important Caveats:
- Most effective when somatic/autonomic symptoms predominate rather than cognitive anxiety 4, 3
- Better suited for "mild tremor of the anxious violinist" than severe panic symptoms 3
- May impair memory recall of difficult items in anxious individuals 2
Chronic Generalized Anxiety Disorder
Propranolol should NOT be used as first-line treatment for chronic generalized anxiety disorder. The most recent and highest quality evidence shows no benefit over placebo for chronic anxiety conditions 5.
Critical Evidence Against Chronic Use:
The 2025 systematic review and meta-analysis found no evidence for beneficial effect of beta-blockers compared with placebo or benzodiazepines in patients with social phobia or panic disorder (p ≥ 0.54 for all comparisons) 5. This represents the definitive current evidence base.
Guideline Recommendations:
The 2023 Japanese Society guidelines explicitly deprecate propranolol for social anxiety disorder based on negative evidence 6. Major international guidelines (NICE, S3, Canadian CPG) do not recommend beta-blockers for chronic anxiety disorders 6.
Historical Context (Now Superseded):
Older studies from the 1980s-1990s suggested potential benefit with:
- 160 mg/day for several weeks in generalized anxiety 3
- 20-40 mg once to three times daily for moderate anxiety with prominent somatic symptoms 4
However, these findings have not been validated by modern high-quality trials 5, and the 2025 meta-analysis definitively shows lack of efficacy.
First-Line Treatments for Chronic Anxiety
Based on guideline evidence, appropriate first-line treatments include:
For children and adolescents (6-18 years):
- SSRIs (sertraline, fluoxetine, escitalopram) as monotherapy 7
- Combination CBT plus SSRI for optimal outcomes 7
For adults with social anxiety disorder:
- SSRIs (escitalopram, sertraline, paroxetine, fluvoxamine) 6
- SNRIs (venlafaxine) 6
- Structured CBT (14 sessions over 4 months) 6
Common Pitfalls to Avoid
- Do not prescribe propranolol for chronic daily anxiety - the evidence does not support this use 5
- Do not use doses above 40 mg for acute situational anxiety - higher doses increase side effects without improving efficacy 1
- Do not expect propranolol to help cognitive symptoms of anxiety - it primarily addresses peripheral somatic symptoms 4, 3
- Monitor for bradycardia and hypotension, especially at doses ≥40 mg 1
- Consider contraindications: asthma, heart block, severe bradycardia, hypotension
When Propranolol May Still Have a Role
The 2024 autism study showed propranolol improved anxiety ratings at 12 weeks (p=0.045, OR=2.58) in this specific population 8, suggesting potential benefit in select cases with prominent autonomic symptoms. However, this remains investigational and does not change recommendations for typical anxiety disorders.